Decreased expression of CD73 (ecto-5'-nucleotidase) in the CD8+ subset is associated with zinc deficiency in human patients

Journal of Laboratory and Clinical Medicine

Volumn 130, Issue 2, 1997, Pages 147-156

  Beck, Frances W J ^a   Kaplan, Joseph ^a   Fine, Nancy ^a   Handschu, Wenonah ^a   Prasad, Ananda S ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031214655     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(97)90091-3     Document Type: Article

References (58)

1. Alford RM. Metal cation requirement for phytohaemagglutinin-induced transformation of human peripheral leukocytes. J Immunol 1970;104:698-703.
2. Bogden JD, Oleske JM, Mumves EM, Lavenhar MA, Brueing KS, Kemp FW, et al. Zinc and immunocompetence in the elderly: baseline data on zinc nutriture and immunity in unsupplemented subjects. Am J Clin Nutr 1987;46:101-9.
3. Kaplan J, Hess JW, Prasad AS. Impaired interleukin-2 production in the elderly: association with mild zinc deficiency. J Trace Elem Exp Med 1988;1:3-8.
4. Fraker PJ, Gershwin ME, Good RA, Prasad AS. Interrelationships between zinc and the immune system. Fed Proc 1986;45:1474-9.
5. Allen JI, Perri RT, McClain CJ, Kay NE. Alterations in human natural killer cell activity and monocyte cytotoxicity induced by zinc deficiency. J Lab Clin Med 1983;102:577-89.
6. Ballester OF, Abdallah JM, Prasad AS. Lymphocyte subpopulation abnormalities in sickle cell anemia: a distinctive pattern from that of AIDS. Am J Hematol 1986;21:23-7.
7. Ketzinel M, Efrat S, Sayar D, Gerez L, Tal C, Deutsch E, et al. Regulation of human interleukin-2 and interferon-gamma gene expression by suppressor T lymphocytes. Scand J Immunol 1991;33:593-605.
8. Kaempfer R. Regulation of the human interleukin-2/interleukin-2 receptor system: a role for immunosuppression. Proc Soc Exp Biol Med 1994;206:176-80.
9. Meftah SP, Prasad AS, Lee DY, Brewer GW. Ecto-5′-nucleotidase (5′NT) as a sensitive indicator of human zinc deficiency. J Lab Clin Med 1991;118:309-16.
10. Bales CW, DiSilvestro RA, Currie KL, Plaisted CS, Joung H, Galonos AN, et al. Marginal zinc deficiency in older adults: responsiveness of zinc status indicators. J Am Coll Nutr 1994;13:455-62.
11. Thompson LF, Reudi JM, O'Conner RD, Bastiani JF. Ecto-5′-nucleotidase expression during human B cell development: an explanation for the heterogeneity in B lymphocyte ecto-5′-nucleotidase activity in patients with hypogamma-globulinemia. J Immunol 1986;137:2496-500.
12. Cohen A, Mansour A, Dosch HM, Gelfand EW. Association of a purine lymphocyte enzyme deficiency (5′-nucleotidase) with combined immunodeficiency. Clin Immunol Immunopathol 1980;15:245-50.
13. Salazar-Gonzalez JF, Moody DJ, Giorgi JV, Martinez-Maza O, Mitsuyasu RT, Fahey JL. Reduced ecto-5′-nucleotidase activity and enhanced OKT10 and HLA-DR expression on CD8 (T suppressor/cytotoxic) lymphocytes in the acquired immune deficiency disease syndrome: evidence of CD8 immaturity. J Immunol 1985;135:1778-85.
14. Massaia M, Dianzani U, Pioppo P, Sibilla E, Boccadoro M, Pileri A. Multiple myeloma: Ecto-5′-nucleotidase deficiency of suppressor/cytotoxic (CD8) lymphocytes is a marker for the expansion of suppressor T cells. Clin Exp Immunol 1987; 69:426-32.
15. Dennes E, Tupper R, Wormall A. The zinc content of erythrocytes and leukocytes of blood from normal and leukemic subjects. Biochem J 1961;78:578-87.
16. Fredricks RE, Tanaka KR, Valentine WN. Variation of human blood cell zinc in disease. J Clin Invest 1964;43:304-15.
17. Kanter RJ, Rai KR, Muniz F, Michael B, Balkan J, Sawitski A. Intracellular zinc in chronic lymphocytic leukemia. Clin Immunol Immunopathol 1982;24:26-32.
18. Cunningham-Rundles C, Cunningham-Rundles S, Iwata T, Incefy G, Garofalo JA, Menendez-Botet C, et al. Zinc deficiency, depressed thymic hormones, and T lymphocyte dysfunction in patients with hypo-gammaglobulinemia. Clin Immunol Immunopathol 1981;21:387-96.
19. Thompson LF, Ruedi JM, Glass A, Moldenhauer G, Moller P, Low MG, et al. Production and characterization of monoclonal antibodies to the glycosyl phosphatidylinositol-anchored lymphocyte differentiation antigen ecto-5′-nucleotidase (CD73). Tissue Antigens 1990;35:9-19.
20. Massaia M, Perrin L, Bianchi A, Ruedi J, Attisano C, Alteri D, et al. Synergy between CD73 (ecto-5′-nucleotidase) and signals delivered through CD3 and CD2 molecules. J Immunol 1990;45:1664-74.
21. Massaia M, Pilleri A, Boccadoro M, Bianchi A. The generation of alloreactive cytotoxic T lymphocytes requires the expression of ecto-5′-nucleotidase activity. J Immunol 1988; 141:3768-75.
22. Clement LT, Grossi CE, Gartland L. Morphologic and phenotypic features of the subpopulation of leu-2+ cells that suppresses B cell differentiation. J Immunol 1984;133:2461-8.
23. Dianzani U, Zarcone D, Pistoia V, Grossi CE, Pileri A, Massaia M, et al. CD8+CD11b+ peripheral blood T lymphocytes contain lymphokine-activated killer cell precursors. Eur J Immunol 1989;19:1037-44.
24. Prasad AS, Cossack ZT. Zinc supplementation and growth in sickle cell disease. Ann Intern Med 1984;100:367-71.
25. Prasad AS. Acquired zinc deficiency and immune dysfunction in sickle cell anemia. In: Cunningham-Rundles S, editor. Nutrient Modulation of the Immune Response. New York: Marcel Dekker, 1992:393-409.
26. Beck FWJ. Ecto-5′-nucleotidase in human lymphocytes: effect of zinc deficiency in sickle cell anemia. [Doctoral thesis.] Detroit: Wayne State University, 1993.
27. Rabbani PI, Prasad AS, Tsai R, Harland BF, Spivey-Fox MRS. Dietary model for the production of experimental zinc deficiency in man. Am J Clin Nutr 1987;45:1514-5.
28. Wang H, Prasad AS, DuMouchelle EA. Zinc in platelets, lymphocytes and granulocytes by flameless atomic absorption spectrophotometry. J Micronutr Anal 1989;5:181-90.
29. Prasad AS, Meftah S, Abdallah J, Kaplan J, Brewer G, Bach JF, et al. Serum thymulin in zinc deficiency. J Clin Invest 1988;82:1202-10.
30. Pilz RB, Willis RC, Seegmiller JE. Regulation of human lymphoblast plasma membrane 5′-nucleotidase by zinc. J Biol Chem 1982;257:13544-9.
31. Daniel WW. Biostatistics: a foundation for analysis in the health sciences. New York: John Wiley & Sons, 1987:1-440.
32. Massaia M, Dianzani U, Pioppo P, Boccadoro M, Redoglia V, Omede P, et al. Emergence of activated lymphocytes in CD4 and CD8 subpopulations of multiple myeloma: correlation with the expansion of suppressor T-cell (CD8+OKM1+) and ecto-5′-nucleotidase deficiency. J Lab Clin Med 1988;26:89-95.
33. Vallee BL, Galdes A. The metallobiochemistry of zinc enzymes. Adv Enzymol Relat Areas Mol Biol 1984;56:283-430.
34. Hambidge KM, Casey CE, Krebs NF. Zinc. In: Mertz W, editor. Trace elements in human and animal nutrition (vol 2). 5th ed. Orlando, FL: Academic Press, 1986:1-137.
35. Prasad AS, Shoomaker EBS, Ortega J, Brewer GJ, Oberleas D, Oelshlegel FJ. Zinc deficiency in sickle cell disease. Clin Chem 1975;21:582-7.
36. Horuzsko A, Gyodi E, Reti M, Mayer K, Kassay M, Petranyi G. Selective effects of noncytotoxic blocking alloantibodies produced after platelet transfusion on MLC, and mitogen and soluble antigen-induced responses of human lymphocytes. Transplantation 1990;50:497-501.
37. National Research Council. Recommended daily allowances. 10th ed. Washington: National Academy of Sciences, 1989.
38. Sandstead HH, Smith C Jr. Deliberations and evaluations of approaches, endpoints and paradigms for determining zinc dietary recommendations. J Nutr 1996;126:2410S-8S.
39. Fernandes G, Nair M, Omoe K, Tanaka T, Floyd R, Good R. Impairment of cell-mediated immunity functions by dietary zinc deficiency in mice. Proc Natl Acad Sci U S A 1979;76: 457-61.
40. Fraker PJ, Jardieu P, Coos J. Zinc deficiency and infection. Arch Dermatol 1987;123:1699-701.
41. Bjornson AB. The immune deficit. In: Embury SH, Hebbel RP, Mohandas N, Steinberg MH, editors. Sickle cell disease: basic principles and clinical practice. New York: Raven Press, 1994:35-348.
42. Calvano SE, DeRiesthal HF, Marano MA, Antonacci AC. The decrease in peripheral blood CD4+ T cells following thermal injury in humans can be accounted for by a concomitant decrease in suppressor-inducer CD4+ T cells as assessed using anti-CD45R. Clin Immunol Immunopathol 1988;47:164-73.
43. Laurence J. T-cell subsets in health, infectious disease, and idiopathic CD4+ T lymphocytopenia. Ann Intern Med 1993; 119:55-66.
44. Miller GG, Strittmatter WJ. Identification of human T cells that require zinc for growth. Scand J Immunol 1992;36:269-277.
45. Thompson LF, Ruedi JM, Low MG, Clement LT. Distribution of ecto-5′-nucleotidase on subsets of human T and B lymphocytes as detected by indirect immuno-fluorescence using goat antibodies. J Immunol 1987;139:4042-8.
46. Christensen LD, Anderson V. Natural killer cells lack ecto-5′-nucleotidase. Nat Immun 1992;1:1-6.
47. Zimmermann H. 5′-Nucleotidase: molecular structure and functional aspects. Biochem J 1992;285:345-65.
48. Fini C, Bertoli E, Albertini G, Floridi A, Tanfani F. Structural and functional relationships in 5′-nucleotidase from bull seminal plasma: a Fourier transform infrared study. Biochim Biophys Acta 1992;1118:187-93.
49. Prasad AS, Beck FWJ, Endre L, Handschu W, Kukuruga M, Kumar G. Zinc deficiency affects cell cycle and deoxythymidine kinase gene expression in HUT-78 cells. J Lab Clin Med 1996;128:51-60.
50. Massaia M, Attisano C, Redoglia V, Bianchi A, Thompson LF, Dianzani U, et al. Amplification of T cell activation induced by CD73 (ecto-5′-nucleotidase) engagement. In: Harkness RA, Elion CB, Zoller N, editors. Purine and pyrimidine metabolism in man (vol. VII, part B). New York: Plenum Press, 1991:155-161.
51. lo (Naive) CD8+ T lymphocytes. J Immunol 1993;151:3961-70.
52. Tsubono M, Nio Y, Shiraishi T, Morimoto H, Tseung CC, Kawabata K, et al. Increased numbers of suppressor T-cells and impaired IL-2 mediated T-cell function in peripheral blood of gastric cancer patients. J Clin Lab Immunol 1990; 33:107-15.
53. MacFarland HI, Nahill SR, Maciaszek JW, Welsh RM. CD11b (Mac-1): a marker for CD8 cytotoxic T cell activation and memory in virus infection. J Immunol 1992;149:1326-33.
54. Buchanan GR. Infections. In: Embury SH, Hebbel RP, Mohandas N, Steinberg MH, editors. Sickle cell disease: basic principles and clinical practice. New York: Raven Press, 1994:567-87.
55. Prasad AS, Kaplan J, Brewer GW, Dardenne M. Immunological effects of zinc deficiency in sickle cell anemia (SCA). In: Brewer GW, editor. The red cell: The Seventh Ann Arbor Conference. New York: Alan R. Liss, 1989:629-49.
56. Frost P, Rabbani P, Smith J, Prasad A. Cell mediated cytotoxicity and tumor growth in zinc deficient mice. Proc Soc Exp Biol Med 1981;167:333-7.
57. Moskophidlis D, Lechner F, Pircher H, Zinkernagel RM. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 1993;362:758-61.
58. Matloubian MR, Concepcion J, Ahmed R. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during viral infection. J Virol 1994;68:8056.